Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of liraglutide (Victoza) in short bowel syndrome patients with end-jejunostomy
2013-005499-16Phase 2Completed
- Sponsor
- Rigshospitalet
- Start
- Jan 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of liraglutide in short bowel syndrome (SBS), intestinal failure (IF) and intestinal malabsorption, sponsored by Rigshospitalet. Primary endpoint: Faecal weight/stoma output. Started Jan 2014; status: completed.
02
Drugs
03
Conditions
short bowel syndrome (SBS)intestinal failure (IF)intestinal malabsorption
Beyond the preview
Go deeper on 2013-005499-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005499-16.